Doxycycline decreases monocyte chemoattractant protein-1 in human lung epithelial cells

Experimental Lung Research

Volumn 32, Issue 1-2, 2006, Pages 15-26

  Raza, Muhammad ^a   Ballering, Janelle G ^a   Hayden, John M ^a,b   Robbins, Richard A ^a,b   Hoyt, Jeffrey C ^a,b  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

CCL2; Chemokine; Doxycycline; Inflammation; Lung; MCP 1

Indexed keywords

DOXYCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHIOLITIS; BRONCHITIS; CELL STRAIN A549; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MONOCYTE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; DOXYCYCLINE; GENE EXPRESSION; HUMANS; MONOCYTES; PNEUMONIA; RESPIRATORY MUCOSA; RNA, MESSENGER;

EID: 33646687965     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140600691399     Document Type: Article

References (31)

1. Koyama S, Rennard SI, Leikauf GD, Robbins RA: Bronchial epithelial cells release monocyte chemotactic activity in response to smoke and endotoxin. J Immunol. 1991;147:972-979.
2. Koyama S, Rennard SI, Leikauf GD, Shoji S, Von Essen S, Claassen L, Robbins RA: Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils. J Immunol. 1991;147:4293-4301.
3. Ekekezie II, Thibeault DW, Garola RE, Truog WE: Monocyte chemoattractant protein-1 and its receptor CCR-2 in piglet lungs exposed to inhaled nitric oxide and hyperoxia. Pediat Res. 2001;50:633-640.
4. Zachariae CO, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, Matsushima K: Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosacrcoma cell line. J Exp Med. 1990;171:2177-2182.
5. Rollins BJ, Waiz A, Baggiolini M: Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood. 1991;78:1112-1116.
6. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992;148:2423-2428.
7. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP: Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992;175:489-493.
8. + T lymphocytes. FASEB J. 1994;8:1055-1060.
9. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemotactic protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 1994;91:3652-3656.
10. Nakashima E, Kubota Y, Matsushita R, Ozaki E, Ichimura F, Kawahara S, Nakanishi I, Kuno K, Matsushima K. Synergistic antitumor interaction of human monocyte chemoattractant protein-1 gene transfer and modulator for tumor-inflitrating macrophages. Pharm Res. 1998;15:685-689.
11. Esplugues E, Sancho D, Vega-Ramos J, Martinez-A C, Syrbe U, Hamann A, Engel P, Sanchez-Madrid F, Lauzurica P: Enhanced antitumor activity immunity in mice deficient in CD69. J Exp Med. 2003;197:1093-1106.
12. Hasegawa M, Sato S, Takehara K: Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha (MIP-1 alpha), and MIP-1 beta) in patients with systemic sclerosis: MCP-1 and MIP-1 alpha may be involved in the development of pulmonary fibrosis. Clin Exp Immunol. 1999;117:159-165.
13. National Heart Lung and Blood Institute/World Health Organization. 2002 NIH Publication No. 02-3659.
14. National Heart Lung and Blood Institute/World Health Organization. 2003. http://www.gold-copd.com/
15. Kharitonov SA, Barnes PJ: Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol. 2001;1:217-224.
16. Avila PC, Boushey HA: Macrolides, asthma inflammation and infection. Ann Allergy Asthma Immunol. 2000;84:565-568.
17. Labro MT: Immunomodulation by antibacterial agents. Is it clinically relevant. Drugs. 1993;45:319-328.
18. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-1423.
19. Robbins RA, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson JJ, Adcock IM, Riveros-Moreno V, Moncada S, Polak J, Barnes PJ: Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun. 1994;198:835-843.
20. Jones KL, Bryan TW, Jinkins PA, Simpson KL, Grisham MB, Owens MW, Milligan SA, Markewitz BA, Robbins RA: Superoxide causes a reduction in nitric oxide gas and an increase in nitrate. Am J Physiol. 1998;275:L1120-L1126.
21. Hartnett BJ, Marlin GE: Doxycycline in serum and bronchial secretions. Thorax. 1976;31:144-148.
22. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89.
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
24. Sato E, Koyama S, Takamizawa A, Masubuchi T, Kubo K, Robbins RA, Nagai S, Izumi T: Smoke extract stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activities. Am J Physiol. 1999;277:L1149-L1157.
25. Daly C, Rollins BJ: Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirulation. 2003;10:247-257.
26. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung disease and injury. Am Rev Respir Dis. 1990;141:471-501.
27. Rose CE, Jr, Sung SS, Fu SM: Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation. 2003;10:273-288.
28. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibenen DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW, III: Azithromycin in patients with cystic fibrosis chronically infected with Pseudommas aeruginosa. JAMA. 2003;290:1749-1756.
29. Gottfried MH: Macrolides for the treatment of chronic sinusitis, asthma and COPD. Chest. 2004;125:52S-61S.
30. Nieman GF, Zerler BR: A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury. Curr Med Chem. 2001;8:317-325.
31. Shinkai M, Foster GH, Rubin BK: Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;290:L75-L85.